Position in GRAL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,864,260
-$2,381,037 QoQ
Shares Held
55,423
-9.6% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $69,634,221 across 18 Diagnostics & Research names. GRAL ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
25,899 | $14,552,389 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
29,028 | $14,268,132 | |
| 3 | DHR |
Danaher Corp /De/
|
48,612 | $9,216,835 | |
| 4 | NTRA |
Natera, Inc.
|
22,942 | $4,588,170 | |
| 5 | TWST |
Twist Bioscience Corp
|
96,255 | $4,574,037 | |
| 6 | VCYT |
Veracyte, Inc.
|
104,212 | $3,356,668 | |
| 7 | GRAL |
GRAIL, Inc.
This page
|
55,423 | $2,864,260 | |
| 8 | A |
Agilent Technologies, Inc.
|
21,858 | $2,491,374 |
All Filings in GRAL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,864,260 | 55,423 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,245,297 | 61,284 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,543,122 | 43,009 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,109,865 | 41,032 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,555,156 | 60,891 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $997,939 | 55,907 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $293,152 | 19,073 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||